Eli Lilly and Novo Nordisk, whose weight-loss-related drugs have caused a frenzy, are working with the Trump administration on a deal that would cut the cost of the lowest doses of their popular drugs to $149 for a month's supply, people familiar with the matter told The Wall Street Journal. As part of the deal, which could be announced as soon as Thursday, the drugs would be sold through TrumpRx, a forthcoming government-run initiative expected to launch next year that will connect consumers directly with drug manufacturers to purchase discounted prescription drugs without insurance.Under the...

3 hours ago

On HALO